| Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic JP Rogers, E Chesney, D Oliver, TA Pollak, P McGuire, P Fusar-Poli, ... The Lancet Psychiatry 7 (7), 611-627, 2020 | 3110 | 2020 |
| Risks of all‐cause and suicide mortality in mental disorders: a meta‐review E Chesney, GM Goodwin, S Fazel World psychiatry 13 (2), 153-160, 2014 | 2504 | 2014 |
| Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials E Chesney, D Oliver, A Green, S Sovi, J Wilson, A Englund, TP Freeman, ... Neuropsychopharmacology 45 (11), 1799-1806, 2020 | 277 | 2020 |
| Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention? A Ilyas, E Chesney, R Patel The British journal of psychiatry 211 (4), 194-197, 2017 | 102 | 2017 |
| Suicide, self-harm and thoughts of suicide or self-harm in infectious disease epidemics: a systematic review and meta-analysis JP Rogers, E Chesney, D Oliver, N Begum, A Saini, S Wang, P McGuire, ... Epidemiology and psychiatric sciences 30, e32, 2021 | 86 | 2021 |
| Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD: THC ratios A Englund, D Oliver, E Chesney, L Chester, J Wilson, S Sovi, A De Micheli, ... Neuropsychopharmacology 48 (6), 869-876, 2023 | 77 | 2023 |
| Cannabidiol (CBD) as a novel treatment in the early phases of psychosis E Chesney, D Oliver, P McGuire Psychopharmacology 239 (5), 1179-1190, 2022 | 43 | 2022 |
| The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study E Chesney, D Robson, R Patel, H Shetty, S Richardson, CK Chang, ... Schizophrenia Research 238, 29-35, 2021 | 38 | 2021 |
| Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products E Chesney, P McGuire, TP Freeman, J Strang, A Englund Therapeutic advances in psychopharmacology 10, 2045125320954992, 2020 | 37 | 2020 |
| Lithium for acute mania RF McKnight, E Chesney, BH Amit, J Geddes, A Cipriani Cochrane database of systematic reviews, 2019 | 35 | 2019 |
| Is paliperidone palmitate more effective than other long-acting injectable antipsychotics? R Patel, E Chesney, M Taylor, D Taylor, P McGuire Psychological Medicine 48 (10), 1616-1623, 2018 | 35 | 2018 |
| Clinical outcomes and mortality associated with weekend admission to psychiatric hospital R Patel, E Chesney, AE Cullen, AD Tulloch, M Broadbent, R Stewart, ... The British Journal of Psychiatry 209 (1), 29-34, 2016 | 23 | 2016 |
| The acute effects of cannabis with and without cannabidiol in adults and adolescents: a randomised, double‐blind, placebo‐controlled, crossover experiment W Lawn, K Trinci, C Mokrysz, A Borissova, S Ofori, K Petrilli, M Bloomfield, ... Addiction 118 (7), 1282-1294, 2023 | 22 | 2023 |
| Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study D Oliver, G Spada, A Englund, E Chesney, J Radua, A Reichenberg, ... Schizophrenia research 226, 176-183, 2020 | 21 | 2020 |
| Life expectancy, mortality risks and cause of death in patients with serious mental illness in South East London: a comparison between 2008-2012 and 2013-2017 CK Chang, E Chesney, WN Teng, S Hollandt, M Pritchard, H Shetty, ... Psychological Medicine, 2021 | 19* | 2021 |
| Suicide, self-harm and thoughts of suicide or self-harm in infectious disease epidemics: a systematic review and meta-analysis–CORRIGENDUM JP Rogers, E Chesney, D Oliver, N Begum, A Saini, S Wang, P McGuire, ... Epidemiology and Psychiatric Sciences 30, e41, 2021 | 13 | 2021 |
| Pathways to care for patients with first-episode psychosis in Singapore E Chesney, E Abdin, LY Poon, M Subramaniam, S Verma The Journal of Nervous and Mental Disease 204 (4), 291-297, 2016 | 12 | 2016 |
| Psychiatric and neuropsychiatric syndromes and COVID-19–Authors' reply JP Rogers, E Chesney, D Oliver, TA Pollak, P McGuire, P Fusar-Poli, ... The Lancet Psychiatry 7 (8), 664-665, 2020 | 9 | 2020 |
| Effects of cannabidiol and delta-9-tetrahydrocannabinol on plasma endocannabinoid levels in healthy volunteers: a randomized double-blind four-arm crossover study LA Chester, A Englund, E Chesney, D Oliver, J Wilson, S Sovi, ... Cannabis and cannabinoid research 9 (1), 188-198, 2024 | 8 | 2024 |
| Exploring causal mechanisms of psychosis risk D Oliver, E Chesney, AE Cullen, C Davies, A Englund, G Gifford, S Kerins, ... Neuroscience & Biobehavioral Reviews, 105699, 2024 | 7 | 2024 |
